Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharat Damle

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|March 10, 2010
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)David R Luke, Konrad Tomaszewski, Bharat Damle, et al.
Journal of Clinical Pharmacology|February 27, 2007
Lack of pharmacokinetic interaction between anidulafungin and tacrolimusJames A Dowell, Martin Stogniew, David Krause, et al.
Journal of Clinical Pharmacology|October 20, 2006
Pharmacokinetics of nelfinavir in subjects with hepatic impairmentBharat Damle, Dial Hewlett, Poe-Hirr Hsyu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2011
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysisDavid R Luke, Nolan D Wood, Konrad E Tomaszewski, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
British Journal of Clinical Pharmacology|January 19, 2010
Assessment of the pharmacokinetics of co-administered maraviroc and raltegravirEmma Andrews, Paul Glue, Juanzhi Fang, et al.
Clinical and Translational Science|September 21, 2020
The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of AzithromycinJack Cook, Milton L Pressler, Bharat Damle, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasisPing Liu, Markus Ruhnke, Wouter Meersseman, et al.
Journal of Clinical Pharmacology|February 28, 2009
Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT studyBharat Damle, Cecilia Fosser, Kaori Ito, et al.
Journal of Clinical Pharmacology|June 4, 2008
Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjectsPing Ji, Bharat Damle, Jingdong Xie, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|March 10, 2010
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)David R Luke, Konrad Tomaszewski, Bharat Damle, et al.
Journal of Clinical Pharmacology|February 27, 2007
Lack of pharmacokinetic interaction between anidulafungin and tacrolimusJames A Dowell, Martin Stogniew, David Krause, et al.
Journal of Clinical Pharmacology|October 20, 2006
Pharmacokinetics of nelfinavir in subjects with hepatic impairmentBharat Damle, Dial Hewlett, Poe-Hirr Hsyu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2011
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysisDavid R Luke, Nolan D Wood, Konrad E Tomaszewski, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
British Journal of Clinical Pharmacology|January 19, 2010
Assessment of the pharmacokinetics of co-administered maraviroc and raltegravirEmma Andrews, Paul Glue, Juanzhi Fang, et al.
Clinical and Translational Science|September 21, 2020
The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of AzithromycinJack Cook, Milton L Pressler, Bharat Damle, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasisPing Liu, Markus Ruhnke, Wouter Meersseman, et al.
Journal of Clinical Pharmacology|February 28, 2009
Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT studyBharat Damle, Cecilia Fosser, Kaori Ito, et al.
Journal of Clinical Pharmacology|June 4, 2008
Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjectsPing Ji, Bharat Damle, Jingdong Xie, et al.
Pageof 4